Ulrike Haessler - Publications

Affiliations: 
École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland 
Area:
Lymphatic System

2/11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Sánchez-Soriano N, Gonçalves-Pimentel C, Beaven R, Haessler U, Ofner-Ziegenfuss L, Ballestrem C, Prokop A. Drosophila growth cones: a genetically tractable platform for the analysis of axonal growth dynamics. Developmental Neurobiology. 70: 58-71. PMID 19937774 DOI: 10.1002/Dneu.20762  0.346
2005 Sánchez-Soriano N, Bottenberg W, Fiala A, Haessler U, Kerassoviti A, Knust E, Löhr R, Prokop A. Are dendrites in Drosophila homologous to vertebrate dendrites? Developmental Biology. 288: 126-38. PMID 16223476 DOI: 10.1016/J.Ydbio.2005.09.026  0.347
Low-probability matches (unlikely to be authored by this person)
2008 Cioffi M, Bottan S, Haessler U, Dixon B, Swartz MA, Boschetti F. MODELLING OF DENDRITIC CELL CHEMOTAXIS IN TISSUE ENGINEERED MICROENVIRONMENTS Journal of Biomechanics. 41: S108. DOI: 10.1016/S0021-9290(08)70108-8  0.2
2011 Haessler U, Pisano M, Wu M, Swartz MA. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19. Proceedings of the National Academy of Sciences of the United States of America. 108: 5614-9. PMID 21422278 DOI: 10.1073/pnas.1014920108  0.186
2009 Haessler U, Kalinin Y, Swartz MA, Wu M. An agarose-based microfluidic platform with a gradient buffer for 3D chemotaxis studies. Biomedical Microdevices. 11: 827-35. PMID 19343497 DOI: 10.1007/s10544-009-9299-3  0.165
2012 Haessler U, Teo JC, Foretay D, Renaud P, Swartz MA. Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber. Integrative Biology : Quantitative Biosciences From Nano to Macro. 4: 401-9. PMID 22143066 DOI: 10.1039/C1Ib00128K  0.142
2014 Greiff V, Menzel U, Haessler U, Cook SC, Friedensohn S, Khan TA, Pogson M, Hellmann I, Reddy ST. Quantitative assessment of the robustness of next-generation sequencing of antibody variable gene repertoires from immunized mice. Bmc Immunology. 15: 40. PMID 25318652 DOI: 10.1186/s12865-014-0040-5  0.092
2019 D'Amico L, Menzel U, Prummer M, Müller P, Buchi M, Kashyap A, Haessler U, Yermanos A, Gébleux R, Briendl M, Hell T, Wolter FI, Beerli RR, Truxova I, Radek Š, et al. A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer. Journal For Immunotherapy of Cancer. 7: 16. PMID 30665463 DOI: 10.1186/s40425-018-0464-1  0.079
2014 Menzel U, Greiff V, Khan TA, Haessler U, Hellmann I, Friedensohn S, Cook SC, Pogson M, Reddy ST. Comprehensive evaluation and optimization of amplicon library preparation methods for high-throughput antibody sequencing. Plos One. 9: e96727. PMID 24809667 DOI: 10.1371/journal.pone.0096727  0.044
2014 Haessler U, Reddy ST. Using next-generation sequencing for discovery of high-frequency monoclonal antibodies in the variable gene repertoires from immunized mice. Methods in Molecular Biology (Clifton, N.J.). 1131: 191-203. PMID 24515467 DOI: 10.1007/978-1-62703-992-5_12  0.038
2016 D'Amico L, Haessler U, Menzel U, Buchi M, Stefan N, Beerli R, Grawunder U, Reddy S, Zippelius A. Dynamics of the global tumor immunome upon treatment with a novel anti-HER2 anthracycline based antibody drug conjugate in breast cancer Annals of Oncology. 27: viii13. DOI: 10.1093/ANNONC/MDW525.41  0.033
Hide low-probability matches.